Autophagy and Alpha‐Synuclein: Relevance to Parkinson's Disease and Related Synucleopathies

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Movement Disorders

• Publication date

  2016-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/mds.26477PMID 26813776
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Treatment with Trehalose Prevents Behavioral and Neurochemical Deficits Produced in an AAV α-Synuclein Rat Model of Parkinson’s Disease

  2016cited by this paper
• LAMP-2 deficiency leads to hippocampal dysfunction but normal clearance of neuronal substrates of chaperone-mediated autophagy in a mouse model for Danon disease

  2015cited by this paper
• Role of α- and β-Synucleins in the Axonal Pathology of Parkinson’s Disease and Related Synucleinopathies

  2015cited by this paper
• Genetic and Chemical Activation of TFEB Mediates Clearance of Aggregated α-Synuclein

  2015cited by this paper
• B1 is involved in autophagy inhibition caused by SNCA/a-synuclein overexpression: a process modulated by the natural autophagy inducer corynoxine B.

  2015cited by this paper
• A53T Human α-Synuclein Overexpression in Transgenic Mice Induces Pervasive Mitochondria Macroautophagy Defects Preceding Dopamine Neuron Degeneration

  2015cited by this paper
• VPS35 in Dopamine Neurons Is Required for Endosome-to-Golgi Retrieval of Lamp2a, a Receptor of Chaperone-Mediated Autophagy That Is Critical for α-Synuclein Degradation and Prevention of Pathogenesis of Parkinson's Disease

  2015cited by this paper
• α-Synuclein-Independent Histopathological and Motor Deficits in Mice Lacking the Endolysosomal Parkinsonism Protein Atp13a2

  2015cited by this paper
• Lysosomal‐associated membrane protein 2 isoforms are differentially affected in early Parkinson's disease

  2015cited by this paper
• 3-Anhydro-6-hydroxy-ophiobolin A, a fungal sesterterpene from Bipolaris oryzae induced autophagy and promoted the degradation of α-synuclein in PC12 cells.

  2015cited by this paper
• Loss of glucocerebrosidase 1 activity causes lysosomal dysfunction and α-synuclein aggregation

  2015cited by this paper
• The role of ATP13A2 in Parkinson's disease: Clinical phenotypes and molecular mechanisms

  2015cited by this paper
• Parkinson's disease genes VPS35 and EIF4G1 interact genetically and converge on α-synuclein.

  2015cited by this paper
• Lysosomal mTORC2/PHLPP1/Akt Regulate Chaperone-Mediated Autophagy.

  2015cited by this paper
• Alpha-Synuclein affects neurite morphology, autophagy, vesicle transport and axonal degeneration in CNS neurons

  2015cited by this paper
• iPSC-derived neurons from GBA1-associated Parkinson’s disease patients show autophagic defects and impaired calcium homeostasis

  2014cited by this paper
• ATP13A2/PARK9 Regulates Secretion of Exosomes and α-Synuclein

  2014cited by this paper
• Development of targeted therapies for Parkinson’s disease and related synucleinopathies

  2014cited by this paper
• In silico modeling of the effects of alpha-synuclein oligomerization on dopaminergic neuronal homeostasis

  2014cited by this paper
• A GCase Chaperone Improves Motor Function in a Mouse Model of Synucleinopathy

  2014cited by this paper
• HMGB1 is involved in autophagy inhibition caused by SNCA/α-synuclein overexpression

  2014cited by this paper
• Mutation in VPS35 associated with Parkinson’s disease impairs WASH complex association and inhibits autophagy

  2014cited by this paper
• Augmentation of phenotype in a transgenic Parkinson mouse heterozygous for a Gaucher mutation.

  2014cited by this paper
• VPS35 dysfunction impairs lysosomal degradation of α-synuclein and exacerbates neurotoxicity in a Drosophila model of Parkinson's disease.

  2014cited by this paper
• Interplay between Sumoylation and Phosphorylation for Protection against α-Synuclein Inclusions*

  2014cited by this paper
• Ambroxol improves lysosomal biochemistry in glucocerebrosidase mutation-linked Parkinson disease cells

  2014cited by this paper
• Autophagosome biogenesis in primary neurons follows an ordered and spatially regulated pathway.

  2014cited by this paper
• Targeted Suppression of Chaperone-Mediated Autophagy by miR-320a Promotes α-Synuclein Aggregation

  2014cited by this paper
• Phosphorylation Modulates Clearance of Alpha-Synuclein Inclusions in a Yeast Model of Parkinson's Disease

  2014cited by this paper
• Formation of α-synuclein Lewy neurite–like aggregates in axons impedes the transport of distinct endosomes

  2014cited by this paper
• c-Abl phosphorylates α-synuclein and regulates its degradation: implication for α-synuclein clearance and contribution to the pathogenesis of Parkinson's disease.

  2014cited by this paper
• C-abl Phosphorylates Alpha-synuclein And Regulates Its Degradation, Implication For Alpha-synuclein Clearance And Contribution To The Pathogenesis Of Parkinson's Disease

  2014cited by this paper
• LIMP-2 expression is critical for β-glucocerebrosidase activity and α-synuclein clearance

  2014cited by this paper
• Overexpression of Human E46K Mutant α-Synuclein Impairs Macroautophagy via Inactivation of JNK1-Bcl-2 Pathway

  2014cited by this paper
• Reduced glucocerebrosidase is associated with increased α-synuclein in sporadic Parkinson's disease.

  2014cited by this paper
• Cargo recognition and trafficking in selective autophagy

  2014cited by this paper
• Autophagy modulates SNCA/α-synuclein release, thereby generating a hostile microenvironment

  2014cited by this paper
• Parkinson's disease-linked human PARK9/ATP13A2 maintains zinc homeostasis and promotes α-Synuclein externalization via exosomes.

  2014cited by this paper
• Glucocerebrosidase depletion enhances cell-to-cell transmission of α-synuclein

  2014cited by this paper
• iPSC-derived dopamine neurons reveal differences between monozygotic twins discordant for Parkinson's disease.

  2014cited by this paper
• Is Parkinson disease associated with lysosomal integral membrane protein type-2?: challenges in interpreting association data.

  2013cited by this paper
• Augmenting CNS glucocerebrosidase activity as a therapeutic strategy for parkinsonism and other Gaucher-related synucleinopathies

  2013cited by this paper
• Influence of microRNA deregulation on chaperone-mediated autophagy and α-synuclein pathology in Parkinson's disease

  2013cited by this paper
• Dysfunction of the autophagy/lysosomal degradation pathway is a shared feature of the genetic synucleinopathies

  2013cited by this paper
• Glucocerebrosidase inhibition causes mitochondrial dysfunction and free radical damage

  2013cited by this paper
• Tubulin Polymerization-promoting Protein (TPPP/p25α) Promotes Unconventional Secretion of α-Synuclein through Exophagy by Impairing Autophagosome-Lysosome Fusion*

  2013cited by this paper
• Loss of β-Glucocerebrosidase Activity Does Not Affect Alpha-Synuclein Levels or Lysosomal Function in Neuronal Cells

  2013cited by this paper
• Selective Autophagy: Talking with the UPS

  2013cited by this paper
• Polo-like kinase 2 regulates selective autophagic α-synuclein clearance and suppresses its toxicity in vivo

  2013cited by this paper
• TFEB-mediated autophagy rescues midbrain dopamine neurons from α-synuclein toxicity

  2013cited by this paper
• Autophagic failure promotes the exocytosis and intercellular transfer of α-synuclein

  2013cited by this paper
• The machinery of macroautophagy

  2013cited by this paper
• Alteration of autophagosomal proteins in the brain of multiple system atrophy.

  2013cited by this paper
• Chemical modulation of chaperone-mediated autophagy by retinoic acid derivatives

  2013cited by this paper
• Lewy Body-like α-Synuclein Aggregates Resist Degradation and Impair Macroautophagy*♦

  2013cited by this paper
• Nilotinib reverses loss of dopamine neurons and improves motor behavior via autophagic degradation of α-synuclein in Parkinson's disease models.

  2013cited by this paper
• The role of SCARB2 as susceptibility factor in Parkinson's disease

  2013cited by this paper
• Lipofuscin: formation, effects and role of macroautophagy☆

  2013cited by this paper
• Boosting chaperone-mediated autophagy in vivo mitigates α-synuclein-induced neurodegeneration.

  2013cited by this paper
• Lysosomal impairment in Parkinson's disease

  2013cited by this paper
• Targeting intracellular and extracellular alpha-synuclein as a therapeutic strategy in Parkinson's disease and other synucleinopathies

  2012cited by this paper
• Involvement of Macroautophagy in Multiple System Atrophy and Protein Aggregate Formation in Oligodendrocytes

  2012cited by this paper
• Association study of SCARB2 rs6812193 polymorphism with Parkinson's disease in Han Chinese.

  2012cited by this paper
• Development and Characterization of a New Parkinson's Disease Model Resulting from Impaired Autophagy

  2012cited by this paper
• Disrupted Autophagy Leads to Dopaminergic Axon and Dendrite Degeneration and Promotes Presynaptic Accumulation of α-Synuclein and LRRK2 in the Brain

  2012cited by this paper
• Glucocerebrosidase Deficiency in Substantia Nigra of Parkinson Disease Brains

  2012cited by this paper
• Differential Effects of UCHL1 Modulation on Alpha-Synuclein in PD-Like Models of Alpha-Synucleinopathy

  2012cited by this paper
• Evidence of an association between the scavenger receptor class B member 2 gene and Parkinson's disease

  2012cited by this paper
• Alpha-synuclein aggregation involves a bafilomycin A1-sensitive autophagy pathway

  2012influential reference
• Alpha-synuclein and Protein Degradation Systems: a Reciprocal Relationship

  2012cited by this paper
• Autophagy and neurodegeneration.

  2012cited by this paper
• Exosomal cell-to-cell transmission of alpha synuclein oligomers

  2012cited by this paper
• Immunohistochemical localization of aggresomal proteins in glial cytoplasmic inclusions in multiple system atrophy

  2012cited by this paper
• A mutation in VPS35, encoding a subunit of the retromer complex, causes late-onset Parkinson disease.

  2011cited by this paper
• Pathological roles of α-synuclein in neurological disorders.

  2011cited by this paper
• Mutant A53T α-Synuclein Induces Neuronal Death by Increasing Mitochondrial Autophagy*

  2011cited by this paper
• Web-Based Genome-Wide Association Study Identifies Two Novel Loci and a Substantial Genetic Component for Parkinson's Disease

  2011cited by this paper
• Acid β‐glucosidase mutants linked to gaucher disease, parkinson disease, and lewy body dementia alter α‐synuclein processing

  2011cited by this paper
• Ubiquitin ligase Nedd4 promotes α-synuclein degradation by the endosomal–lysosomal pathway

  2011cited by this paper
• Lysosomal Proteolysis Inhibition Selectively Disrupts Axonal Transport of Degradative Organelles and Causes an Alzheimer's-Like Axonal Dystrophy

  2011cited by this paper
• Lysosomal dysfunction increases exosome-mediated alpha-synuclein release and transmission

  2011cited by this paper
• α-Synuclein fate is determined by USP9X-regulated monoubiquitination

  2011cited by this paper
• α-Synuclein Interacts with Glucocerebrosidase Providing a Molecular Link between Parkinson and Gaucher Diseases*

  2011cited by this paper
• CNS expression of glucocerebrosidase corrects α-synuclein pathology and memory in a mouse model of Gaucher-related synucleinopathy

  2011cited by this paper
• Distinct Roles In Vivo for the Ubiquitin–Proteasome System and the Autophagy–Lysosomal Pathway in the Degradation of α-Synuclein

  2011cited by this paper
• Gaucher disease glucocerebrosidase and α-synuclein form a bidirectional pathogenic loop in synucleinopathies.

  2011cited by this paper
• Accumulation and distribution of α-synuclein and ubiquitin in the CNS of Gaucher disease mouse models.

  2011cited by this paper
• A photoconvertible fluorescent reporter to track chaperone-mediated autophagy

  2011cited by this paper
• AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1

  2011cited by this paper
• Selective Molecular Alterations in the Autophagy Pathway in Patients with Lewy Body Disease and in Models of α-Synucleinopathy

  2010cited by this paper
• Ubiquilin functions in autophagy and is degraded by chaperone-mediated autophagy.

  2010cited by this paper
• Nix is a selective autophagy receptor for mitochondrial clearance

  2010cited by this paper
• Lysosomal Degradation of α-Synuclein in Vivo*

  2010cited by this paper
• Mammalian autophagy: core molecular machinery and signaling regulation.

  2010cited by this paper
• Pathogenic Lysosomal Depletion in Parkinson's Disease

  2010cited by this paper
• Chaperone-mediated autophagy markers in Parkinson disease brains.

  2010cited by this paper
• α-Synuclein impairs macroautophagy: implications for Parkinson’s disease

  2010cited by this paper
• Identification of regulators of chaperone-mediated autophagy.

  2010cited by this paper
• Ubiquilin at a crossroads in protein degradation pathways

  2010cited by this paper
• Regulation of Neuronal Survival Factor MEF2D by Chaperone-Mediated Autophagy

  2009cited by this paper

• Nucleophagy: The guardian of genome stability - from molecular mechanisms to disease associations.

  2026cites this paper
• Intranasally Delivered Mesenchymal Stem Cells Reverses Prodromal Non-Motor Deficits and Nigral Loss in a Parkinson’s Disease Mouse Model

  2026cites this paper
• Gaps in the Parkinson's disease therapeutic clinical pipeline: A focus on approaches targeting disease pathobiology.

  2025cites this paper
• Combination treatment with rapamycin and glucocorticoid protects the death of mesostriatal dopaminergic neurons in animal model of Parkinson's disease.

  2025cites this paper
• A novel stable transgenic zebrafish line expressing mCherry-tagged human alpha-synuclein in the nervous system and exhibiting all the key features of Lewy body disorders at larval stage.

  2025cites this paper
• Rab27b Promotes Lysosomal Function and Alpha-Synuclein Clearance in Neurons

  2025cites this paper
• KFERQ-selective protein autophagy in Caenorhabditis elegans depends on LMP-1

  2025cites this paper
• Apigenin enhances Nrf2-induced chaperone-mediated autophagy and mitigates α-synuclein pathology: Implications for Parkinson's disease therapy.

  2025cites this paper
• Electroacupuncture Ameliorated Locomotor Symptoms in MPTP-Induced Mice Model of Parkinson's Disease by Regulating Autophagy via Nrf2 Signaling.

  2025cites this paper
• Targeting the glymphatic system to promote α-synuclein clearance: a novel therapeutic strategy for Parkinson’s disease

  2025influential citation
• Neuronal alpha-synuclein-mediated autophagy drives lipid droplets accumulation in astrocytes and microglia and aggravates ischemic stroke.

  2025cites this paper
• Modest improvement of metabolic and behavioral deficits with long-term ambroxol treatment in a Pink1-/-SNCAA53T double mutant mouse model of Parkinson's disease.

  2025cites this paper
• Autophagy related genes polymorphisms in Parkinson’s Disease; A systematic review of literature

  2025cites this paper
• SGLT2 inhibitors vs. metformin for Parkinson's disease risk reduction in type 2 diabetes

  2025cites this paper
• α-Synuclein targeted therapy with multiple pathological improvement for Parkinson's disease by macrocyclic amphiphile nanomedicine.

  2025cites this paper
• Astrocyte Autophagy in Neurodegenerative Diseases: Current Progress in Mechanisms and Therapeutics

  2025cites this paper
• Autophagy-related proteomics reveals lysosomal alterations linked to C19orf12 mutations and candidate biomarkers in MPAN patients' fibroblasts.

  2025cites this paper
• The role of fatty acids in neurodegenerative diseases: mechanistic insights and therapeutic strategies

  2025cites this paper
• Identification of Key Active Constituents in Eucommia ulmoides Oliv. Leaves Against Parkinson’s Disease and the Alleviative Effects via 4E-BP1 Up-Regulation

  2025cites this paper
• Investigating Neuroprotective Effects of Berberine on Mitochondrial Dysfunction and Autophagy Impairment in Parkinson’s Disease

  2025cites this paper
• Targeting the Interplay Between Autophagy and the Nrf2 Pathway in Parkinson’s Disease with Potential Therapeutic Implications

  2025cites this paper
• A Global Perspective of GBA1-Related Parkinson’s Disease: A Narrative Review

  2024cites this paper
• Sex Differences in Parkinson’s Disease: A Narrative Review

  2024cites this paper
• Alpha-synuclein regulates the repair of genomic DNA double-strand breaks in a DNA-PKcs-dependent manner

  2024cites this paper
• A partial Drp1 knockout improves autophagy flux independent of mitochondrial function

  2024cites this paper
• β-Asarone inhibitsAutophagy by activating the PI3K/Akt/mTOR Pathway in a Rat Model of Depression in Parkinson's Disease.

  2024cites this paper
• Research Priorities on the Role of α‐Synuclein in Parkinson's Disease Pathogenesis

  2024cites this paper
• The impact of VPS35 D620N mutation on alternative autophagy and its reversal by estrogen in Parkinson's disease

  2024cites this paper
• Myclobutanil induces neurotoxicity by activating autophagy and apoptosis in zebrafish larvae (Danio rerio).

  2024cites this paper
• Emerging perspectives on precision therapy for Parkinson’s disease: multidimensional evidence leading to a new breakthrough in personalized medicine

  2024cites this paper
• Protein tyrosine phosphatase receptor type O serves as a key regulator of insulin resistance-induced α-synuclein aggregation in Parkinson’s disease

  2024cites this paper
• Modeling Lewy body disease with SNCA triplication iPSC-derived cortical organoids and identifying therapeutic drugs

  2024cites this paper
• Interfering with aggregated α-synuclein in advanced melanoma leads to a major upregulation of MHC class II proteins

  2024cites this paper
• α-Synuclein disrupts microglial autophagy through STAT1-dependent suppression of Ulk1 transcription

  2024cites this paper
• Lysosomal dysfunction in α-synuclein pathology: molecular mechanisms and therapeutic strategies

  2024cites this paper
• A-Syn(ful) MAM: A Fresh Perspective on a Converging Domain in Parkinson’s Disease

  2024cites this paper
• A Mutual Nexus Between Epilepsy and α-Synuclein: A Puzzle Pathway

  2024cites this paper
• Alpha-synuclein, autophagy-lysosomal pathway, and Lewy bodies: Mutations, propagation, aggregation, and the formation of inclusions

  2024cites this paper
• RIT2 regulates autophagy lysosomal pathway induction and protects against α-synuclein pathology in a cellular model of Parkinson's disease.

  2024cites this paper
• Salsolinol as an RNA m6A methylation inducer mediates dopaminergic neuronal death by regulating YAP1 and autophagy

  2024cites this paper
• Mesencephalic astrocyte-derived neurotrophic factor inhibits neuroinflammation through autophagy-mediated α-synuclein degradation.

  2024cites this paper
• α-Synuclein in Parkinson's Disease: 12 Years Later.

  2024cites this paper
• Prospects for Disease Slowing in Parkinson Disease.

  2024cites this paper
• Therapeutic Implications and Regulations of Protein Post-translational Modifications in Parkinsons Disease

  2024cites this paper
• Alpha-synuclein modulates the repair of genomic DNA double-strand breaks in a DNA-PKcs-regulated manner

  2024cites this paper
• DNA repair deficiencies and neurodegeneration.

  2024cites this paper
• Piperine promotes PI3K/AKT/mTOR-mediated gut-brain autophagy to degrade α-Synuclein in Parkinson's disease rats.

  2023cites this paper
• Clinical biomarkers for Lewy body diseases

  2023cites this paper
• Immunization Effects of a Novel α-Synuclein-Based Peptide Epitope Vaccine in Parkinson’s Disease-Associated Pathology

  2023cites this paper
• Neuroprotective effects of osmotin in Parkinson’s disease-associated pathology via the AdipoR1/MAPK/AMPK/mTOR signaling pathways

  2023cites this paper
• Upregulation of Parkinson's disease-associated protein alpha-synuclein suppresses tumorigenesis via interaction with mGluR5 and gamma-synuclein in liver cancer.

  2023cites this paper
• Computational investigation on the effect of the peptidomimetic inhibitors (NPT100-18A and NPT200-11) on the α-synuclein and lipid membrane interactions

  2023cites this paper
• Histone Deacetylase 4 Inhibition Reduces Rotenone-Induced Alpha-Synuclein Accumulation via Autophagy in SH-SY5Y Cells

  2023cites this paper
• The alleviative effect of Calendula officinalis L. extract against Parkinson’s disease-like pathology in zebrafish via the involvement of autophagy activation

  2023cites this paper
• SAR Study of Niclosamide Derivatives for Neuroprotective Function in SH-SY5Y Neuroblastoma.

  2023cites this paper
• Genetic Evidence for Endolysosomal Dysfunction in Parkinson’s Disease: A Critical Overview

  2023cites this paper
• The ‘α-synucleinopathy syndicate’: multiple system atrophy and Parkinson’s disease

  2023cites this paper
• Regulators of proteostasis are translationally repressed in fibroblasts from patients with sporadic and LRRK2-G2019S Parkinson’s disease

  2023cites this paper
• Modulating SQSTM1/p62-dependent selective autophagy of neurons by activating Nrf2 with multifunctional nanoparticles to eliminate α-synuclein aggregates and boost therapy of Parkinson’s disease

  2023cites this paper
• SARS‐COV‐2 infection and Parkinson's disease: Possible links and perspectives

  2023cites this paper
• Alpha‐synuclein‐associated changes in PINK1‐PRKN‐mediated mitophagy are disease context dependent

  2023cites this paper
• Limonene, a Monoterpene, Mitigates Rotenone-Induced Dopaminergic Neurodegeneration by Modulating Neuroinflammation, Hippo Signaling and Apoptosis in Rats

  2023cites this paper
• Disrupting the α-synuclein-ESCRT interaction with a peptide inhibitor mitigates neurodegeneration in preclinical models of Parkinson’s disease

  2023cites this paper
• A partial Drp1 knockout improves autophagy flux independent of mitochondrial function

  2023cites this paper
• Autophagy in Parkinson’s Disease

  2023cites this paper
• Curcumin Modulates p62-Keap1-Nrf2-Mediated Autophagy in Rotenone-Induced Parkinson's Disease Mouse Models.

  2023cites this paper
• ATP13A2 Gene Silencing in Drosophila Affects Autophagic Degradation of A53T Mutant α-Synuclein

  2023cites this paper
• Nicotine-mediated rescue of α-synuclein toxicity requires synaptic vesicle glycoprotein 2

  2022cites this paper
• Semaglutide Protects against 6-OHDA Toxicity by Enhancing Autophagy and Inhibiting Oxidative Stress

  2022cites this paper
• GSNOR deficiency attenuates MPTP-induced neurotoxicity and autophagy by facilitating CDK5 S-nitrosation in a mouse model of Parkinson's disease.

  2022cites this paper
• Precision Medicine in Parkinson’s Disease: From Genetic Risk Signals to Personalized Therapy

  2022influential citation
• Implications of intracellular protein degradation pathways in Parkinson's disease and therapeutics

  2022influential citation
• Opicapone, a Novel Catechol-O-methyl Transferase Inhibitor, for Treatment of Parkinson's Disease "Off" Episodes.

  2022cites this paper
• From cradle to grave: neurogenesis, neuroregeneration and neurodegeneration in Alzheimer’s and Parkinson’s diseases

  2022cites this paper
• The Roles of ATP13A2 Gene Mutations Leading to Abnormal Aggregation of α-Synuclein in Parkinson’s Disease

  2022cites this paper
• Artemisia Leaf Extract protects against neuron toxicity by TRPML1 activation and promoting autophagy/mitophagy clearance in both in vitro and in vivo models of MPP+/MPTP-induced Parkinson's disease.

  2022cites this paper
• Correlation of Ferroptosis and Other Types of Cell Death in Neurodegenerative Diseases

  2022cites this paper
• What have we learned from genome-wide association studies (GWAS) in Parkinson disease?

  2022cites this paper
• Monocyte biomarkers define sargramostim treatment outcomes for Parkinson's disease

  2022cites this paper
• Telomerase and neurons: an unusual relationship

  2022cites this paper
• CB2R Activation Regulates TFEB-Mediated Autophagy and Affects Lipid Metabolism and Inflammation of Astrocytes in POCD

  2022cites this paper
• Nutraceuticals as Modulators of Autophagy: Relevance in Parkinson’s Disease

  2022cites this paper
• Aberrant Dopamine Homeostasis as a Focal Point in the Mechanism of Environmental Contaminant-Induced Dopaminergic Dysfunction

  2022cites this paper
• The potential applications of traditional Chinese medicine in Parkinson's disease: A new opportunity.

  2022cites this paper
• The role of autophagy-related proteins in the pathogenesis of neuromyelitis optica spectrum disorders

  2022cites this paper
• Cell–Cell Communication Alterations via Intercellular Signaling Pathways in Substantia Nigra of Parkinson’s Disease

  2022cites this paper
• Quantitative Metabolomic Analysis of Changes in the Rat Blood Serum during Autophagy Modulation: A Focus on Accelerated Senescence

  2022cites this paper
• Reelin protects against pathological α-synuclein accumulation and dopaminergic neurodegeneration after environmental enrichment in Parkinson's disease.

  2022cites this paper
• Pathogenesis of α-Synuclein in Parkinson’s Disease: From a Neuron-Glia Crosstalk Perspective

  2022cites this paper
• Mechanistic models of α-synuclein homeostasis for Parkinson's disease: A blueprint for therapeutic intervention

  2022cites this paper
• Regulators of proteostasis are translationally repressed in fibroblasts from sporadic and LRRK2-G2019S Parkinson’s patients

  2022cites this paper
• Interaction between autophagy and the NLRP3 inflammasome in Alzheimer’s and Parkinson’s disease

  2022cites this paper
• Kaemperfol Protects Dopaminergic Neurons by Promoting mTOR-Mediated Autophagy in Parkinson’s Disease Models

  2022cites this paper
• MANF Inhibits α-Synuclein Accumulation through Activation of Autophagic Pathways

  2022influential citation
• Passive Immunization in Alpha-Synuclein Preclinical Animal Models

  2022cites this paper
• Modelling the Functional Genomics of Parkinson’s in Caenorhabditis elegans: LRRK2 and Beyond

  2021cites this paper
• An Emerging Role for Phosphoinositides in the Pathophysiology of Parkinson’s Disease

  2021cites this paper
• Sirtuins and Autophagy in Age-Associated Neurodegenerative Diseases: Lessons from the C. elegans Model

  2021cites this paper
• Diterpene glycosides from Holothuria scabra exert the α-synuclein degradation and neuroprotection against α-synuclein-Mediated neurodegeneration in C. elegans model.

  2021cites this paper
• OPTH_A_323944 4005..4014

  2021cites this paper